Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for XPR. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: XPR is a Sell candidate.
XPR price ended at $0.002407 on 星期四, after rising 12.69%
On Feb 05, 2026 00:00, the price of XPR rose by 12.69%, climbing from $0.002567 to $0.002407 with 24h trading volume reaching $2.4M XPR.